Intended for healthcare professionals


Websites selling AMH “fertility” tests use false or misleading claims, researchers find

BMJ 2023; 382 doi: (Published 23 August 2023) Cite this as: BMJ 2023;382:p1951
  1. Elisabeth Mahase
  1. The BMJ

Tests for the anti-müllerian hormone (AMH) are being marketed as measures of fertility using claims that could lead to “misplaced anxiety or reassurance” and could change people’s plans for contraception or conception, researchers have warned.1

A research team based in Australia identified 27 websites in the US, India, UK, Canada, Ireland, the Netherlands, and Australia that sold direct-to-consumer AMH tests. They said that, despite evidence that the test cannot reliably predict current or future fertility, three quarters (20) of the …

View Full Text

Log in

Log in through your institution


* For online subscription